Advanced Analytics

Parallel Trade Management

Impact assessment and strategy

Alira Health provides pharmaceutical and medical device companies support in assessing the impact of parallel trade on their financial performance and reputation.
We take a quantitative approach that aims to reconstruct parallel export flows at the European level. This identifies and prioritizes the markets where we may need to redefine distribution strategy and commercial agreements.

Together, we’ll work closely to design effective launch strategies aimed at managing parallel trade at the local and corporate level.

In-house training and support

We can also provide solutions designed to increase internal awareness and support sustainable performance management. Our approach includes training operational teams and consolidating reference data sources to EU-level value generation rather than country-specific volumes.

A global team of trade and data experts

When you partner with Alira Health, you gain access to a global team of data and parallel trade experts with over 15 years of pharmaceutical and medical device industry experience.

Together, we’ll build data-driven, comprehensive strategies designed to empower your company’s tools and capabilities.

Related News

MedTech
News March 3, 2021
The 2021 MedTech Contract Manufacturing Report
Download our latest piece: The 2021 MedTech Contract Manufacturing Report. Learn how despite the ongoing pandemic, the Medical Device and CDMO industries are positioned to perform(...)
M&A
Publications February 28, 2021
What’s most important when selecting a firm for your next transaction?
Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
M&A
Publications February 24, 2021
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more download our latest TAD Infographic.
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
Regulatory
News February 2, 2021
We Secured Breakthrough Device Designation from FDA on PEDRA Xauron Perfusion System
We are proud to announce the firm’s Regulatory practice has secured a Breakthrough Device Designation from FDA for the real-time tissue perfusion system, PEDRA Xauron Perfusion System.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.